ISIN: DK0060257814 · Zealand Pharma A/S · © Danish Financial Supervisory Authority

Short Selling Alert: Capital Fund Management

Message date: 18th November 2024

Termsheet of the Shortselling Transaction

As a result of the registered transaction Increased the share of the short position changed from 0,50% to 0,62%. Within the transaction history, this is the 3rd adjustment of the short position since the initial commitment of 29th April 2024.
Snapshot transaction history
-%
0,52%
0,50%

0,62%

Fifteen (15) companies specializing in short selling have Zealand Pharma A/S on their short-selling radar. The total share of all short selling positions is 7,26%. The largest share is held by Perceptive Advisors LLC with 0,72%.
Weighting of the position within the overall ranking: 67

OMXCOP:ZEAL Price indication powered by TradingView

Research & Analysis

Short Selling Radar Europe

Corporate Insights | Information for investors and traders

360°
SSR reporting for: 18th November 2024

Short Selling Radar (Denmark)

Select Country

In this overview, we provide you with short sale holdings visually prepared and enriched with further relevant information for supplementary information and research purposes. The reporting requirements are defined via the specifications of corresponding guidelines and recorded by a publicly accessible register at the Finanstilsynet1 . For validation of the data, consult at least a second source.

Tip: If you have a user account with ayondo, you can use the ayondo smart alerts to be notified when net short positionschange, ratings or ad-hoc announcements of listed companies via auto alert.

Reset filters
This might be interesting for you as well
Equity Story (0)
Analyst Ratings (0)
Directors Dealings (0)
Short Selling (DE) (0)
Short Selling (UK) (0)
Click on that Icon to get Support from AI
DK0060257814
Short Selling Transaction Report from
18th November 2024

Termsheet of the Shortselling Transaction

Capital Fund Management
As a result of the registered transaction Increased the share of the short position changed from 0,50% to 0,62%. Within the transaction history, this is the 3rd adjustment of the short position since the initial commitment of 29th April 2024.
-%
0,52%
0,50%

0,62%

Fifteen (15) companies specializing in short selling have Zealand Pharma A/S on their short-selling radar. The total share of all short selling positions is 7,26%. The largest share is held by Perceptive Advisors LLC with 0,72%.
Weighting of the position within the overall ranking: 67
More info:
DK0060257814
Short Selling Transaction Report from
7th November 2024

Termsheet of the Shortselling Transaction

Qube Research & Technologies Ltd
As a result of the registered transaction Increased the share of the short position changed from 0,51% to 0,55%. Within the transaction history, this is the 12th adjustment of the short position since the initial commitment of 25th August 2022.
0,55%
0,51%
0,51%

0,55%

Fifteen (15) companies specializing in short selling have Zealand Pharma A/S on their short-selling radar. The total share of all short selling positions is 7,26%. The largest share is held by Perceptive Advisors LLC with 0,72%.
Weighting of the position within the overall ranking: 358
More info:
DK0060257814
Short Selling Transaction Report from
9th July 2024

Termsheet of the Shortselling Transaction

Arrowstreet Capital Limited Partnership
As a result of the registered transaction Increased the share of the short position changed from 0,57% to 0,61%. Within the transaction history, this is the 16th adjustment of the short position since the initial commitment of 18th May 2021.
0,51%
0,61%
0,57%

0,61%

Fifteen (15) companies specializing in short selling have Zealand Pharma A/S on their short-selling radar. The total share of all short selling positions is 7,26%. The largest share is held by Perceptive Advisors LLC with 0,72%.
Weighting of the position within the overall ranking: 129
More info:
DK0060257814
Short Selling Transaction Report from
22nd August 2023

Termsheet of the Shortselling Transaction

Perceptive Advisors LLC
As a result of the registered transaction decreased the share of the short position changed from 0,95% to 0,72%. Within the transaction history, this is the 6th adjustment of the short position since the initial commitment of 28th June 2023.
0,91%
1,01%
0,95%

0,72%

Fifteen (15) companies specializing in short selling have Zealand Pharma A/S on their short-selling radar. The total share of all short selling positions is 7,26%. The largest share is held by Perceptive Advisors LLC with 0,72%.
Weighting of the position within the overall ranking: 23
More info:
More related information
Type Total Last Made by Go to
Equity Story 0 - - EQS
Corporate Research 0 - - Corporate Research
Directors Dealings 0 - - DD
Short Seller (DE) 0 - - SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Note

The information prepared here is for informational purposes. The source data comes from the authority responsible for publication - the Danish Financial Market Authority Finanstilsynet . Validation via another source is recommended before further inclusion, e.g. in investment decisions.

.

Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.